• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553660
Device Problems Premature Activation (1484); Use of Device Problem (1670); Device-Device Incompatibility (2919)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/23/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(6).Although the suspect device has been received, the evaluation has not been completed.Therefore, the cause of the reported malfunction has not been determined.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that a hot axios stent was to be implanted in the pylorus to treat a pyloric stricture during a gastroduodenostomy procedure performed on (b)(6) 2019.According to the complainant, during the procedure, while the axios delivery system was being advanced over a guidewire, the coating stripped off the guidewire, and the first flange of the stent prematurely deployed inside the scope.The guidewire was cut to allow for removal of the axios delivery system from the scope.The device was removed from the scope with the stent still partially deployed on the delivery system.Another hot axios stent and another guidewire were used to complete the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: the hot axios stent was being implanted in the pylorus to treat a pyloric stricture; however, the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6cm in size and walled-off necrosis >= 6cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.
 
Manufacturer Narrative
Block h6: device code 1484 captures the reportable event of stent first flange premature deployment.Block h10: a hot axios stent and delivery system was returned for analysis.A visual examination of the device noted that the outer sheath was pulled back slightly from the nosecone, exposing the distal end of the stent.The stent deployment hub was in its original position, the catheter hub was moved proximally, and the catheter lock was in the locked position.The yellow safety clip was not returned.A functional evaluation was performed, and the catheter hub advanced and retracted without resistance.The stent deployment hub was also able to be moved without resistance.The stent was able to be fully deployed without any resistance or issue.The stent was measured to be within specifications.There were no other issues noted.A labeling review was performed, and there is evidence that the device was used in a manner inconsistent with the labeling.The hot axios stent was being implanted in the pylorus to treat a pyloric stricture; however, the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6cm in size and walled-off necrosis >= 6cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.The reported deployment issues indicate operational difficulties experienced during the procedure and are likely due to anatomical or procedural factors.Some echoendoscope and elevator positions result in excess friction between the catheter and the working channel.Friction can impact the performance of the device.Procedural factors, such as the handling of the device and normal procedural difficulties encountered during the procedure, could have possibly affected the device performance and its integrity contributing to the reported event.Therefore, a review and analysis of all available information indicated that the most probable root cause is adverse event related to procedure.A review of the device history record (dhr) confirmed that the device met all material, assembly, and product specifications.
 
Event Description
It was reported to boston scientific corporation that a hot axios stent was to be implanted in the pylorus to treat a pyloric stricture during a gastroduodenostomy procedure performed on (b)(6), 2019.According to the complainant, during the procedure, while the axios delivery system was being advanced over a guidewire, the coating stripped off the guidewire, and the first flange of the stent prematurely deployed inside the scope.The guidewire was cut to allow for removal of the axios delivery system from the scope.The device was removed from the scope with the stent still partially deployed on the delivery system.Another hot axios stent and another guidewire were used to complete the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: the hot axios stent was being implanted in the pylorus to treat a pyloric stricture; however, the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts >= 6cm in size and walled-off necrosis >= 6cm in size with >= 70% fluid content that are adherent to the gastric or bowel wall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key9226888
MDR Text Key178742815
Report Number3005099803-2019-05064
Device Sequence Number1
Product Code PCU
UDI-Device Identifier08714729951179
UDI-Public08714729951179
Combination Product (y/n)N
PMA/PMN Number
K163272
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/15/2020
Device Model NumberM00553660
Device Catalogue Number5366
Device Lot Number0024276570
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/09/2019
Date Manufacturer Received12/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-